Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2
Transcript of Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2
![Page 1: Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2](https://reader034.fdocument.org/reader034/viewer/2022042607/55834825d8b42a8f548b4bdd/html5/thumbnails/1.jpg)
Prostate α/β Ratio and Transition to Hypofractionation
MN Lakshmanan
![Page 2: Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2](https://reader034.fdocument.org/reader034/viewer/2022042607/55834825d8b42a8f548b4bdd/html5/thumbnails/2.jpg)
“It is rare that nature hands us a cancer situation where an improved treatment goes hand in hand with a shorter and more convenient one.”
J.F. Fowler. Development of radiobiology for oncology - a personal view. Physics in medicine and biology, 51(13):263, 2006.
1) Hypofractionation to improve therapeutic gain2) Calculation of α/β Ratio 3) Opposing Arguments4) Additional Considerations
![Page 3: Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2](https://reader034.fdocument.org/reader034/viewer/2022042607/55834825d8b42a8f548b4bdd/html5/thumbnails/3.jpg)
1) Hypofractionation to improve therapeutic gain
![Page 4: Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2](https://reader034.fdocument.org/reader034/viewer/2022042607/55834825d8b42a8f548b4bdd/html5/thumbnails/4.jpg)
J.F. Fowler. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncologica, 44(3):265-276, 2005.
![Page 5: Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2](https://reader034.fdocument.org/reader034/viewer/2022042607/55834825d8b42a8f548b4bdd/html5/thumbnails/5.jpg)
J.F. Fowler. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncologica, 44(3):265-276, 2005.
![Page 6: Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2](https://reader034.fdocument.org/reader034/viewer/2022042607/55834825d8b42a8f548b4bdd/html5/thumbnails/6.jpg)
Modeling Hypofractionation
J.F. Fowler. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncologica, 44(3):265-276, 2005.
![Page 7: Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2](https://reader034.fdocument.org/reader034/viewer/2022042607/55834825d8b42a8f548b4bdd/html5/thumbnails/7.jpg)
2) Calculation of α/β Ratio
![Page 8: Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2](https://reader034.fdocument.org/reader034/viewer/2022042607/55834825d8b42a8f548b4bdd/html5/thumbnails/8.jpg)
J. Fowler, R. Chappell, and M. Ritter. Is α/β for prostate tumors really low? International Journal of Radiation Oncology Biology Physics, 50(4):1021-1031, 2001.
![Page 9: Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2](https://reader034.fdocument.org/reader034/viewer/2022042607/55834825d8b42a8f548b4bdd/html5/thumbnails/9.jpg)
J. Fowler, R. Chappell, and M. Ritter. Is α/β for prostate tumors really low? International Journal of Radiation Oncology Biology Physics, 50(4):1021-1031, 2001.
![Page 10: Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2](https://reader034.fdocument.org/reader034/viewer/2022042607/55834825d8b42a8f548b4bdd/html5/thumbnails/10.jpg)
3) Opposing Arguments
• A) Repopulation times
• B) Tumor Heterogeneity
• C) Hypoxia
![Page 11: Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2](https://reader034.fdocument.org/reader034/viewer/2022042607/55834825d8b42a8f548b4bdd/html5/thumbnails/11.jpg)
J.Z. Wang, M. Guerrero, and X.A. Li. How low is the α/β ratio for prostate cancer? International journal of radiation oncology, biology, physics, 55(1):194-203, 2003.
Assumed a fast repopulation time to get
α/β = 3 Gy
![Page 12: Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2](https://reader034.fdocument.org/reader034/viewer/2022042607/55834825d8b42a8f548b4bdd/html5/thumbnails/12.jpg)
J.F. Fowler. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncologica, 44(3):265-276, 2005.
![Page 13: Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2](https://reader034.fdocument.org/reader034/viewer/2022042607/55834825d8b42a8f548b4bdd/html5/thumbnails/13.jpg)
Tumor Heterogeneity
C.R. King and C.S. Mayo. Is the prostate α/βratio of 1.5 from Brenner & Hall a modeling artifact? International Journal of Radiation Oncology, Biology, Physics, 47(2):536-538, 2000.
Obtained α/β = 5 Gy.
![Page 14: Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2](https://reader034.fdocument.org/reader034/viewer/2022042607/55834825d8b42a8f548b4bdd/html5/thumbnails/14.jpg)
A.E. Nahum, B. Movsas, E.M. Horwitz, C.C. Stobbe, and J.D. Chapman. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the α/β ratio. International journal of radiation oncology, biology, physics, 57(2):391-401, 2003.
![Page 15: Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2](https://reader034.fdocument.org/reader034/viewer/2022042607/55834825d8b42a8f548b4bdd/html5/thumbnails/15.jpg)
4) Additional Considerations
-acute mucosal reaction of rectum
-d = 10 Gy has been used
-improvements in IMRT
![Page 16: Prostate alpha/beta Ratio & Transition to Hypofractionation, part 1/2](https://reader034.fdocument.org/reader034/viewer/2022042607/55834825d8b42a8f548b4bdd/html5/thumbnails/16.jpg)
Conclusions & Future Work
• Low- & Intermendiate-risk patients
• Hypoxia?